An image of a mock medicine bottle

#Training those in the #biopharmaceutical industry?

Our modules are media-rich, narrated by a VA, animated, and built by SMEs.

See www.skillpad.com for more information.

#biotech #elearning #lifesciences

Original post on expressional.social

**Video - Cuban Medication Offers Hope for Millions, U.S. Policy Blinds Us - Dr Bill Blanchet**
https://peertube.world/w/6jcnxpwQ2ctDj2d9dBGNDR
Duration - 24:50

[a #video about #Cuba from _#BellyOfTheBeast_]

> “NeuralCIM is so effective as a new drug, this should change the narrative.”
>
> […]

Perceptive Discovery Unveils Expansion in Preclinical Oncology Research Capabilities Perceptive Discovery enhances its Needham, MA lab capabilities, significantly advancing preclinical oncology research through a strategic expansion.

Perceptive Discovery Unveils Expansion in Preclinical Oncology Research Capabilities #United_States #Biopharmaceutical #Needham #oncology_research #Perceptive_Discovery

Hoth Therapeutics Secures $2 Million Funding through Registered Direct Offering Hoth Therapeutics has announced a successful $2 million registered direct offering, aiming to enhance its clinical-stage biopharmaceutical initiatives and improve patient care.

Hoth Therapeutics Secures $2 Million Funding through Registered Direct Offering #USA #New_York #Biopharmaceutical #Hoth_Therapeutics #NASDAQ_HOTH

Immunic Expands Leadership Team with Industry Veteran Jon Congleton for Strategic Growth Immunic, Inc. enhances its Board of Directors by appointing Jon Congleton, a biopharmaceutical expert, to drive innovations in neurologic disease therapies.

Immunic Expands Leadership Team with Industry Veteran Jon Congleton for Strategic Growth #United_States #New_York #Biopharmaceutical #Immunic_Inc #Jon_Congleton

Precigen's Leadership to Discuss Innovative Medicines in Fireside Chat on March 31 Join Precigen's Dr. Helen Sabzevari and Phil Tennant as they engage in a fireside chat with H.C. Wainwright on March 31, focusing on advancements in precision medicines.

Precigen's Leadership to Discuss Innovative Medicines in Fireside Chat on March 31 #United_States #Biopharmaceutical #Germantown #Precigen #H.C._Wainwright

Precigen's Transformative 2025: Financial Results and Strategic Milestones Unveiled Precigen, Inc. has reached a transformative phase in 2025 with the launch of PAPZIMEOS, revealing impressive financial results and strategic updates.

Precigen's Transformative 2025: Financial Results and Strategic Milestones Unveiled #USA #Biopharmaceutical #Germantown #Precigen #PAPZIMEOS

Azitra Secures $10.5 Million in Private Placement Financing for Innovative Dermatology Solutions Azitra, Inc. has announced a significant private placement financing of approximately $10.5 million, enhancing its capabilities in dermatological innovation through advanced protein and peptide research.

Azitra Secures $10.5 Million in Private Placement Financing for Innovative Dermatology Solutions #United_States #Biopharmaceutical #dermatology #Azitra #Branford

Scinai Immunotherapeutics Faces Nasdaq Minimum Bid Price Notification Scinai Immunotherapeutics Ltd. has received a notification from Nasdaq regarding its non-compliance with minimum bid price rules, allowing them time to comply.

Scinai Immunotherapeutics Faces Nasdaq Minimum Bid Price Notification #NASDAQ #Israel #Jerusalem #Biopharmaceutical #Scinai

IDBS Receives Biologics Digitalisation Software Innovation Award at ABEA 2026 WOKING, United Kingdom — IDBS, a cloud software provider serving the biopharmaceutical industry and part of the Danaher group, has been recognised with the Best Biologics Digitalisation: Software Innovation Award at the Asia Pacific Biopharma Excellence Awards (ABEA) 2026. The award highlights the company’s role in advancing digital transformation and strengthening innovation within the biopharmaceutical …

IDBS Receives Biologics Digitalisation Software Innovation Award at ABEA 2026 #Biopharmaceutical #DigitalTransformation #InnovationAward #Biologics #CloudSoftware

Addressing Patent Myths Activist groups routinely accuse companies of “abusing” the patent system by engaging in practices such as “royalty stacking,” “patent evergreening,” “product hopping,”...

It is because of the patent system that the #UnitedStates is the world leader in #biopharmaceutical #innovation.

Weakening the #patent system won't lower prices for #patients. It would undermine medical progress.

Learn more about the patent system:

Stramsen Biotech Achieves $19 Billion Valuation, Eyes Investment Partnerships and Law Firms Stramsen Biotech's valuation reaches $19 billion, driving job creation and economic growth while seeking partnerships with investment banks and law firms.

Stramsen Biotech Achieves $19 Billion Valuation, Eyes Investment Partnerships and Law Firms #United_States #Houston #Biopharmaceutical #Stramsen_Biotech #SBRX

mAbxience Chooses Genedata Bioprocess to Streamline CDMO Operations for Enhanced Efficiency mAbxience partners with Genedata to leverage innovative software for automating biopharmaceutical workflows, improving operational efficiency and data integrity.

mAbxience Chooses Genedata Bioprocess to Streamline CDMO Operations for Enhanced Efficiency #Switzerland #Biopharmaceutical #Basel #mAbxience #Genedata

Decoy Therapeutics Plans a Reverse Stock Split to Comply with Nasdaq Listing Rule Decoy Therapeutics Inc. announces a 1-for-12 reverse stock split, aiming for compliance with Nasdaq’s minimum bid price requirement.

Decoy Therapeutics Plans a Reverse Stock Split to Comply with Nasdaq Listing Rule #USA #Cambridge #Biopharmaceutical #Decoy_Therapeutics #DCOY

Insmed Announces Inducement Grants Aimed at Attracting New Talent to Biopharmaceutical Company Insmed Incorporated has granted inducement awards to 85 new employees as part of their plan under Nasdaq Listing Rule 5635(c)(4), enhancing talent acquisition.

Insmed Announces Inducement Grants Aimed at Attracting New Talent to Biopharmaceutical Company #United_States #NASDAQ #Biopharmaceutical #Bridgewater #Insmed_Corporation

Antheia Gains $9 Million to Reinforce Domestic Pharmaceutical Supply Chains Antheia announces an additional $9 million funding to bolster domestic pharmaceutical supply chains. This shows the U.S. commitment towards advanced pharmaceutical manufacturing.

Antheia Gains $9 Million to Reinforce Domestic Pharmaceutical Supply Chains #United_States #Menlo_Park #Biopharmaceutical #Antheia #BioMaP

#Biopharmaceutical manufacturing starts with science.

Build #biotech capability where it matters.

Explore our Biotechnology for Biopharmaceutical Manufacturing suite at: www.skillpad.com

#BiotechManufacturing #GMPTraining #Biologics #CellAndGeneTherapy #elearning #training

Contamination control depends on personnel behavior and inspection readiness starts with consistent gowning practices.

Explore our Aseptic Processing modules at Skillpad.com

Link in bio 🔗

#asepticprocessing #pharmaceutical #biopharmaceutical #biotech #elearning #inspectionready

CIMG Inc. Expands Biopharmaceutical Footprint with Acquisition of Daren Business Technology Limited CIMG Inc. has announced its acquisition of Daren Business Technology Limited, aiming to penetrate the biopharmaceutical sector and drive innovation in digital health.

CIMG Inc. Expands Biopharmaceutical Footprint with Acquisition of Daren Business Technology Limited #Biopharmaceutical #CIMG_Inc. #Daren_Tech

AsymBio Launches Comprehensive Biopharmaceutical Development Tech Platforms AsymBio has developed integrated technology platforms that streamline the biopharmaceutical development lifecycle, enhancing innovation and efficiency.

AsymBio Launches Comprehensive Biopharmaceutical Development Tech Platforms #China #Shanghai #Biopharmaceutical #AsymBio #Technology_Platforms

AsymBio Launches Integrated Technology Platforms to Transform Biopharmaceutical Development AsymBio has introduced comprehensive integrated technology platforms aimed at revolutionizing the biopharmaceutical development lifecycle, enhancing efficiency.

AsymBio Launches Integrated Technology Platforms to Transform Biopharmaceutical Development #China #Shanghai #Technology #Biopharmaceutical #AsymBio

AsymBio Launches Integrated Technology Platforms for Biopharmaceutical Development AsymBio, a subsidiary of Asymchem Group, has unveiled integrated technology platforms covering the entire biopharmaceutical development cycle, enhancing efficiency.

AsymBio Launches Integrated Technology Platforms for Biopharmaceutical Development #China #Shanghai #Technology #Biopharmaceutical #AsymBio

Insights and Innovations from the 2026 China Forum on New Drug Discovery The 2026 China Forum on New Drug Discovery brought together industry leaders, emphasizing innovation in drug development, especially amidst rising competition.

Insights and Innovations from the 2026 China Forum on New Drug Discovery #China #Shanghai #Biopharmaceutical #Sanyou_Bio #Drug_Innovation

Piramal Pharma Limited Reports Q3 and 9-Month Results for FY2026 Discover the latest financial results of Piramal Pharma Limited for the third quarter and the first nine months of FY 2026, highlighting key metrics and trends.

Piramal Pharma Limited Reports Q3 and 9-Month Results for FY2026 #India #Mumbai #Biopharmaceutical #Piramal_Pharma #Kenalog

Celltrion Showcases Innovative Drug Development Strategies at J.P. Morgan Healthcare Conference At the J.P. Morgan Healthcare Conference, Celltrion outlines a robust roadmap for drug development, expanding U.S. manufacturing and R&D capabilities, signaling its commitment to innovation.

Celltrion Showcases Innovative Drug Development Strategies at J.P. Morgan Healthcare Conference #South_Korea #Drug_Development #Biopharmaceutical #Incheon #Celltrion

Kelun-Biotech to Showcase Innovations at the 44th J.P. Morgan Healthcare Conference Kelun-Biotech will present its advancements at the 44th J.P. Morgan Healthcare Conference in January 2026, highlighting its innovative strategies.

Kelun-Biotech to Showcase Innovations at the 44th J.P. Morgan Healthcare Conference #United_States #San_Francisco #J.P._Morgan #Biopharmaceutical #Kelun-Biotech

GBI Biomanufacturing Welcomes Jesse McCool as New President to Drive Growth GBI Biomanufacturing appoints Jesse McCool, Ph.D., as the new president, aiming to enhance its integrated services for biopharma innovators amidst industry growth.

GBI Biomanufacturing Welcomes Jesse McCool as New President to Drive Growth #United_States #Fort_Lauderdale #Biopharmaceutical #GBI_Biomanufacturing #Jesse_McCool

Everest Medicines Set to Showcase Innovations at J.P. Morgan Healthcare Conference Everest Medicines is preparing to present key updates at the upcoming J.P. Morgan Healthcare Conference in San Francisco, highlighting its focus on innovative therapies.

Everest Medicines Set to Showcase Innovations at J.P. Morgan Healthcare Conference #China #Shanghai #J.P._Morgan #Biopharmaceutical #Everest_Medicines

Neurocrine Biosciences Set to Present at Esteemed J.P. Morgan Healthcare Conference Neurocrine Biosciences is scheduled to present at the 44th J.P. Morgan Healthcare Conference on January 12, 2026. CEO Kyle Gano will discuss key developments.

Neurocrine Biosciences Set to Present at Esteemed J.P. Morgan Healthcare Conference #United_States #San_Francisco #Biopharmaceutical #Neurocrine_Biosciences #J.P._Morgan_Conference

Insmed Set to Present Innovative Therapies at J.P. Morgan Healthcare Conference Insmed Incorporated, a biopharmaceutical company, will present groundbreaking therapies at the upcoming 44th J.P. Morgan Healthcare Conference in San Francisco.

Insmed Set to Present Innovative Therapies at J.P. Morgan Healthcare Conference #United_States #healthcare #Biopharmaceutical #Bridgewater #Insmed